Laboratory-confirmed pediatric COVID-19 in patients with rheumatic diseases: A case series in a tertiary hospital

Lupus. 2021 Apr;30(5):856-860. doi: 10.1177/0961203321998427. Epub 2021 Mar 2.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Brazil / epidemiology
  • COVID-19 Testing / methods
  • COVID-19* / epidemiology
  • COVID-19* / immunology
  • COVID-19* / physiopathology
  • COVID-19* / therapy
  • Child
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Outcome and Process Assessment, Health Care
  • Retrospective Studies
  • Rheumatic Diseases* / diagnosis
  • Rheumatic Diseases* / drug therapy
  • Rheumatic Diseases* / epidemiology
  • Rheumatic Diseases* / virology
  • Risk Assessment
  • Risk Factors
  • SARS-CoV-2 / isolation & purification*
  • Symptom Assessment* / methods
  • Symptom Assessment* / statistics & numerical data
  • Tertiary Care Centers / statistics & numerical data

Substances

  • Antirheumatic Agents
  • Immunosuppressive Agents